Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page. This appears to be a versioning update rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-03-05T19:28:40.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.2 and removes Revision: v3.4.1, which appears to be a minor version label change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T05:11:27.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Version numbers updated from v3.4.0 to v3.4.1; no user-facing changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T03:44:32.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary toggle, updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision tag to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T22:23:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed instead of v3.3.3. This is a minor site version update and does not alter any study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-14T07:27:36.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added listing study sites in Arizona, District of Columbia, Minnesota, Missouri, New York, South Dakota, and Texas, and the page revision updated to v3.3.3. The previous state-specific subsections (Arizona Locations, District of Columbia Locations, Minnesota Locations, Missouri Locations, New York Locations, South Dakota Locations, Texas Locations) and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.9%
    Check dated 2025-12-23T23:59:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.